ScholarIQanswers from OpenAlex & ORCID
Alberto Ortíz
ResearcherPublications, citations & collaboration network
Alberto Ortíz is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Alberto Ortíz have?
ScholarIQindexed works
Alberto Ortíz has 1,492 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Alberto Ortíz have?
ScholarIQcitation count
Alberto Ortíz has 215,030 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Alberto Ortíz?
ScholarIQh-index
Alberto Ortíz has an h-index of 128 in OpenAlex.
What is the i10-index of Alberto Ortíz?
ScholarIQi10-index
Alberto Ortíz has an i10-index of 805 in OpenAlex.
What is the ORCID of Alberto Ortíz?
ScholarIQorcid
The ORCID for Alberto Ortíz is on the source record.
What is the OpenAlex record for Alberto Ortíz?
ScholarIQopenalex
The OpenAlex for Alberto Ortíz is on the source record.
What are the most-cited papers on Alberto Ortíz?
ScholarIQmost cited works
Chronic kidney disease and the global public health agenda: an international consensus
Anna Francis, Meera N. Harhay, Albert Ong, Sri Lekha Tummalapalli, Alberto Ortíz, Agnes B. Fogo, Danilo Fliser, Prabir Roy‐Chaudhury, Monica Fontana, Masaomi Nangaku, Christoph Wanner, Charu Malik, Anne Hradsky, Dwomoa Adu, Sunita Bavanandan, Ana María Cusumano, Laura Solá, Ifeoma Ulasi, Vivekanand Jha, American Society of Nephrology, International Society of Nephrology
Fabry disease revisited: Management and treatment recommendations for adult patients
Alberto Ortíz, Dominique P. Germain, Robert J. Desnick, Juan Politei, Michael Mauer, Alessandro P. Burlina, Christine M. Eng, Robert J. Hopkin, Dawn A. Laney, Aleš Linhart, Stephen Waldek, Eric Wallace, Frank Weidemann, William R. Wilcox
The systemic nature of CKD
Carmine Zoccali, Raymond Vanholder, Ziad A. Massy, Alberto Ortíz, Pantelis Sarafidis, Friedo W. Dekker, Danilo Fliser, Denis Fouque, Gunnar H. Heine, Kitty J. Jager, Mehmet Kanbay, Francesca Mallamaci, Gianfranco Parati, Patrick Rossignol, Andrzej Wiecek, Gerard London
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure
Alberto Ortíz, Adrian Covic, Danilo Fliser, Denis Fouque, David Goldsmith, Mehmet Kanbay, Francesca Mallamaci, Ziad A. Massy, Patrick Rossignol, R. Vanholder, Andrzej Więcek, Carmine Zoccali, Gérard M. London
Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA
Alberto Ortíz, Mario Cozzolino, Danilo Fliser, Denis Fouque, Dimitrios Goumenos, Ziad A. Massy, Alexander R. Rosenkranz, Ivan Rychlík, María José Soler, Kate Stevens, Roser Torrá, Serhan Tuğlular, Christoph Wanner, Ron T. Gansevoort, ERACODA Working Group, Raphaël Duivenvoorden, Casper Franssen, Marc H. Hemmelder, Luuk B. Hilbrands, Kitty J. Jager, Marlies Noordzij, Priya Vart, Ron T Gansevoort